Get started
Award

Rf-2016-02364358

Funded outputs count: 39
Funder award ID: RF-2016-02364358
OpenAlex ID: G303857671
Diagnostic Uptake of Targeted Sequencing in Adults With Steatotic Liver Disease and a Suspected Genetic Contribution
2025 · Luisa Ronzoni, Serena Pelusi, et al. · Liver International · 3
PDF
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
2024 · Oveis Jamialahmadi, Antonio De Vincentis, et al. · Nature Medicine · 141
PDF
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
2024 · Alessandro Cherubini, Sara Della Torre, et al. · Trends in Molecular Medicine · 153
PDF
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
2024 · Alessandro Mantovani, Alessandro Csermely, et al. · Gut · 45
The contribution of genetics and epigenetics to MAFLD susceptibility
2024 · Vittoria Moretti, Stefano Romeo, et al. · Hepatology International · 42
PDF
Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD
2024 · Serena Pelusi, Luisa Ronzoni, et al. · Clinical Gastroenterology and Hepatology · 15
PDF
Estrogen–ER‐α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women
2024 · Alessandro Cherubini, Elia Casirati, et al. · Clinical and Translational Medicine · 4
PDF
Predictors of controlled attenuation parameter in metabolic dysfunction
2023 · Cristiana Bianco, Serena Pelusi, et al. · United European Gastroenterology Journal · 13
PDF
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV ‐2 infection and COVID ‐19 disease severity
2023 · Philip R. Tedbury, Candela Manfredi, et al. · The FASEB Journal · 5
PDF
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
2023 · Alessandro Cherubini, Mahnoosh Ostadreza, et al. · Nature Medicine · 135
PDF
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction
2023 · Alessandro Mantovani, Serena Pelusi, et al. · Alimentary Pharmacology & Therapeutics · 20
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
2023 · Mary Patricia Moore, Xiaobo Wang, et al. · JHEP Reports · 15
PDF
Consensus Statement on the definition and classification of metabolic hyperferritinaemia
2023 · Luca Valenti, Elena Corradini, et al. · Nature Reviews Endocrinology · 108
PDF
CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
2022 · Hongxue Shi, Xiaobo Wang, et al. · Science Translational Medicine · 82
PDF
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death
2022 · G. Assante, A. Tourna, et al. · Scientific Reports · 7
PDF
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
2022 · Frauke Degenhardt, David Ellinghaus, et al. · Human Molecular Genetics · 108
PDF
PSD3 downregulation confers protection against fatty liver disease
2022 · Rosellina M. Mancina, Kavitha Sasidharan, et al. · Nature Metabolism · 44
PDF
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
2021 · Hamish Innes, Hans Dieter Nischalke, et al. · Hepatology Communications · 24
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
2021 · Alessandro Cherubini, Elia Casirati, et al. · Expert Opinion on Therapeutic Targets · 79
A genetic hypothesis for burnt‐out steatohepatitis
2021 · Luca Valenti, Stefano Romeo, et al. · Liver International · 14
PDF
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study
2021 · Luca Valenti, Serena Pelusi, et al. · Hepatology Communications · 15
PDF
Untitled
2021 · Arrese, Marco; Arab, Juan P.; Barrera, Francisco; Kaufmann, Benedikt; Valenti, Luca; Feldstein, Ariel E.: · Seminars in Liver Disease
PDF
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
2021 · Tomoko Nakanishi, Sara Pigazzini, et al. · Journal of Clinical Investigation · 127
PDF
Is there an ‘ideal’ diet for patients with NAFLD?
2021 · Nicola Pugliese, Maria Corina Plaz Torres, et al. · European Journal of Clinical Investigation · 65
PDF
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders”
2021 · Elena Corradini, Luca V. Valenti · Journal of Hepatology · 2
Year
Topic